Checkmate Pharmaceuticals Inc. Soared
Tue, Apr 19, 2022 at 05:30 PM
Checkmate Pharmaceuticals Inc. (CMPI:NASDAQ) shot up at $10.35, a gain of 325.9%. On Mon, Apr 18, 2022, CMPI:NASDAQ touched a New 2-Week Low of $2.41. The stock appeared on our News Catalysts scanner on Tue, Apr 19, 2022 at 03:08 PM in the 'ACQUISITION' category. From Tue, Apr 05, 2022, the stock recorded 12.50% Up Days and 22.22% Green Days
About Checkmate Pharmaceuticals Inc. (CMPI:NASDAQ)
Checkmate Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing its proprietary technology to harness the power of the immune system to combat cancer.
Top 10 Gainers:
- Checkmate Pharmaceuticals Inc. (CMPI:NASDAQ), 325.93%
- Sharps Technology Inc. (STSS:NASDAQ), 40.46%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 37.01%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 33.29%
- Terran Orbital Corporation (LLAP:NYSE), 28.35%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 26.39%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 25.14%
- Zymergen Inc. (ZY:NASDAQ), 22.56%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 21.85%
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 20.91%